Working… Menu
Trial record 2 of 3 for:    carrimycin

Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04672564
Recruitment Status : Recruiting
First Posted : December 17, 2020
Last Update Posted : May 25, 2021
Information provided by (Responsible Party):
Shenyang Tonglian Group CO., Ltd

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 30, 2021
Estimated Study Completion Date : October 30, 2021